Aller au contenu
Retour à la recherche

NCT07479407Pas encore en recrutement

Effect of Pre-operative Exercise Training on Cardiorespiratory Fitness in Patients With Locally Advanced Non-small Cell Lung Cancer Undergoing Induction Chemo-immunotherapy Followed by Surgery - a Randomized Controlled Study

Résumé

The PREHAB study focuses on patients with locally advanced non-small cell lung cancer (NSCLC) undergoing neoadjuvant chemotherapy and/or immunotherapy prior to surgical resection. These systemic treatments frequently impair patients' physiological reserve, reduce physical fitness, and may occasionally lead to cancellation of surgery. Surgery itself carries a substantial risk of cardiorespiratory complications and long-term functional decline. The primary objective of this study is to determine whether a supervised exercise program, initiated concomitantly with systemic therapy and continued until surgery, can improve cardiorespiratory fitness, surgical tolerance, and postoperative outcomes. A total of 74 patients will be randomly assigned to one of two groups: an "intervention" group participating in three weekly sessions of supervised endurance and resistance training for 12 to 16 weeks under the guidance of a physiotherapist, and a "control" group receiving usual care without a structured exercise program. The primary endpoint will be peak oxygen uptake (VO₂peak). Secondary outcomes will include postoperative complication rates, length of hospital stay, pulmonary function, skeletal muscle mass, and quality of life. Intervention-related risks, primarily falls or overexertion, will be mitigated through professional supervision. This multicenter study, with recruitment scheduled to begin in 2026, is expected to provide robust evidence regarding the effectiveness of targeted exercise training in improving preoperative fitness and postoperative recovery in patients with locally advanced NSCLC.

Critères d'inclusion

• Age ≥18 years. • Confirmed diagnosis of stage IIB, IIIA, IIIB or oligo-metastatic stage IV NSCLC. • Planned induction therapy with either chemotherapy, immunotherapy or a combination of immuno-chemotherapy followed by an anatomical pulmonary resection. • Absence of musculoskeletal conditions preventing safe physical exercise. • Absence of any history of uncontrolled or unstable cardiac disease. • Agreement to participate in the study by signing the study specific informed consent form.

Critères d'exclusion

• Pregnancy (confirmed by a test if applicable). • Induction therapy already initiated. • Inability to walk independently. • Lack of decision-making capacity. • Oxygen-dependency before the initiation of the induction protocol. • No capacity for discernment. • Does not speak French.

Contacts

Les coordonnées de l'équipe de l'essai s'affichent sur demande.

Voir la fiche officielle de l'essai
Statut
Pas encore en recrutement
Phase
Sans phase (N/A)
Type d'étude
Interventionnelle
Pays
Suisse
Promoteur
Hôpital du Valais(Autre)
N° de protocole
Preoperative exercise training
Pathologies
Locally Advanced Non-small Cell Lung Cancer (NSCLC)
Interventions
Procédure

Traitements évalués

  • Preoperative Exercise Training

Collaborateurs

University Hospital, Geneva, Centre Hospitalier Universitaire Vaudois

Lieux · 3

  • Geneva, SuisseHôpitaux Universitaires de GenèveRecrutement pas encore ouvert dans ce centre
  • Lausanne, SuisseCentre Hospitalier Universitaire VaudoisRecrutement pas encore ouvert dans ce centre
  • Sion, SuisseHôpital de SionRecrutement pas encore ouvert dans ce centre

Au total, dans le monde, les 3 centres listés au registre sont prévus ; le recrutement n'est pas encore ouvert.

Statut par centre selon le registre ClinicalTrials.gov (dernière mise à jour publiée : 18 mars 2026).

Ce statut peut avoir changé et ne dit rien de votre éligibilité : avant toute démarche, vérifiez avec votre oncologue ou le centre.

Voir aussi

Autres versions

Ces résultats sont indicatifs et ne remplacent pas un avis médical — à discuter avec votre médecin.